See the latest Compass Minerals International Inc stock price (CMP:XNYS), related news, valuation, dividends and more to help you make your investing decisions.

Novo Nordisk's GLP-1 agonist semaglutide, used to treat diabetes and obesity, may cause a serious eye condition that can lead to the loss of vision, according to the EU medicines regulator. After ...